Anavex Life Sciences Corp. (AVXL) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Anavex Life Sciences Corp. (AVXL) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

AVXL Cash Flow Statement

Anavex Life Sciences Corp. (AVXL) cash flow statement — 22-year operating, investing & financing cash flows

Metric	Q3'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-13.54M	-7.15M	-8.6M	-12.46M	-5.86M	-12.12M	-6.66M	-5.18M	-11.66M	-7.32M	-5.85M	-7.65M	-8.49M	-5.79M	-4.04M	-7.05M	-9.64M	-3.5M	-7.67M	-7.52M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-8.6%	41%	-29.23%	-140.62%	49.76%	-65.62%	-13.82%	32.31%	-37.31%	-26.3%	-44.65%	-8.5%	11.94%	-65.5%	47.31%	6.22%	-31.74%	55.52%	-22.7%	-85.97%
Net Income	7.82M	-5.68M	-9.83M	-13.24M	-11.2M	-12.11M	-11.62M	-12.21M	-10.55M	-8.62M	-10.15M	-11.28M	-13.11M	-12.97M	-14.29M	-12.37M	-10.44M	-10.88M	-11.72M	-10.18M
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	-16.77M	1.11M	3.72M	4.32M	1.45M	2.06M	2.01M	2.49M	2.65M	2.29M	3.19M	3.87M	3.97M	5.35M	6.04M	3.99M	4.44M	3.91M	3.15M	2.29M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-7.17M	0	0	0	0	0	59K	-59K	0	0	500	0	845K	0	0	0	0	0	0	0
Working Capital Changes	2.58M	-2.58M	-2.5M	-3.54M	3.89M	-2.06M	2.89M	4.61M	-3.76M	-982K	1.11M	-239K	-197K	1.83M	4.2M	1.33M	-3.64M	3.47M	891.69K	365.27K
Change in Receivables	35K	-35K	11K	-154K	1.89M	-108K	-729K	2.06M	-236K	-840K	-543.45K	2.57M	-643K	-902K	3.37M	-90.84K	-1.1M	3.76M	-535.57K	-1.27M
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.02M	-1.61M	-2.49M	2.01M	167K	-5.06M	6.07M	-164K	-566K	-30K	168.93K	-2.13M	993K	1.46M	697.88K	495K	-2M	-104.99K	563.07K	518.65K
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	113K	36.32M	10.02M	-2.14M	852K	708K	89K	4.55M	7.28M	59K	2.06M	9M	18.33M	258K	2.44K	6.91M	11.84M	2.54M	2.22M	89.22M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	36.32M	10.46M	119K	852K	708K	89K	4.11M	7.28M	59K	1.19M	8.53M	18.15M	258.24K	2.52K	6.58M	12.09M	2.31M	4	91.28M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	113K	0	-445K	-2.26M	0	0	0	444K	0	0	868.34K	469K	181.5K	258K	-75	327.91K	-251.3K	226.78K	2.22M	-2.06M
Net Change in Cash	-9.1M	29.17M	1.41M	-14.61M	-5M	-11.41M	-6.57M	-630K	-4.38M	-7.26M	-3.79M	1.35M	9.85M	-5.54M	-4.04M	-143.2K	2.2M	-961.39K	-5.45M	81.7M
Free Cash Flow	-13.54M	-7.15M	-8.6M	-12.46M	-5.86M	-12.12M	-6.66M	-5.18M	-11.66M	-7.32M	-5.85M	-7.65M	-8.49M	-5.79M	-4.04M	-7.05M	-9.64M	-3.5M	-7.67M	-7.52M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-8.6%	41%	-29.23%	-140.62%	49.76%	-65.62%	-13.82%	32.31%	-37.31%	-26.3%	-44.65%	-8.5%	11.94%	-65.5%	47.31%	6.22%	-31.74%	55.52%	-22.7%	-85.97%
FCF per Share	-0.15	-0.08	-0.10	-0.15	-0.07	-0.14	-0.08	-0.06	-0.14	-0.09	-0.07	-0.09	-0.11	-0.07	-0.05	-0.09	-0.13	-0.05	-0.10	-0.11
FCF Conversion (FCF/Net Income)	4.24x	1.26x	0.88x	0.94x	0.52x	1.00x	0.57x	0.42x	1.11x	0.85x	0.58x	0.68x	0.65x	0.45x	0.28x	0.57x	0.92x	0.32x	0.65x	0.74x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	41K	16K	73K	-7K	43K	80K	0	173K	47K	-72.58K	69K	90K	50K	185.53K	0	141.37K	0	0	39K